Intra-arterial chemotherapy as second-line treatment for advanced retinoblastoma
Journal Of Cancer Research And TherapeuticsPeer ReviewedHua Jiang +32018Journals
To evaluate the effectiveness and complications of intra-arterial chemotherapy (IAC) for treating advanced refractory retinoblastoma (RB) in a large single-center cohort.
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support